Incremento de supervivencia en melanoma - page 14

N=834

Pembrolizumab

Ipilimumab

Keynote 006

Robert et

. N Eng J Med 2015; Schachter et al. SMR 2015; Schachter ASCO 2016

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,4,5,6,7,8,9,10,11,12,13 15,16,17,18,19,20,21,22,23,24,...29